🇺🇸 Nalcrom in United States

178 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Hypersensitivity — 28 reports (15.73%)
  2. Anaphylactic Shock — 20 reports (11.24%)
  3. Urticaria — 20 reports (11.24%)
  4. Pruritus — 19 reports (10.67%)
  5. Blood Pressure Increased — 16 reports (8.99%)
  6. Blood Glucose Increased — 15 reports (8.43%)
  7. Bone Pain — 15 reports (8.43%)
  8. Gait Disturbance — 15 reports (8.43%)
  9. Perfume Sensitivity — 15 reports (8.43%)
  10. Skin Reaction — 15 reports (8.43%)

Source database →

Nalcrom in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Nalcrom approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Nalcrom in United States?

Universitaire Ziekenhuizen KU Leuven is the originator. The local marketing authorisation holder may differ — check the official source linked above.